A large, randomized, controlled 12-week trial of eszopiclone (Lunesta, Sunovion Pharmaceuticals Inc) in children and adolescents with ADHD and insomnia was no better than placebo in treating the sleep disorder. This study comes on the heels of an earlier ...
from Meta Search Alerts http://ift.tt/1uYk9YA
via IFTTT
from Meta Search Alerts http://ift.tt/1uYk9YA
via IFTTT
No comments:
Post a Comment